University of Toronto Researchers Develop Ferritin-Based MRI Technique for Monitoring Stem Cell-Derived Cardiac Cells

Researchers at the University of Toronto’s Institute of Biomedical Engineering have developed a new magnetic resonance imaging (MRI) technique called “bright ferritin MRI” that allows for long-term monitoring of transplanted stem cell-derived cardiac cells. This method represents a significant advancement in tracking the progress and effectiveness of stem cell therapies in cardiac medicine, providing researchers with a tool to observe these cells over extended periods.

The technique utilizes ferritin, a naturally occurring iron storage protein, to enhance MRI signals. By engineering the transplanted stem cell-derived cardiac cells to produce ferritin, researchers can make them more visible on MRI scans. This approach enables non-invasive and prolonged observation of the cells’ behavior and integration into heart tissue after transplantation. The development addresses a critical challenge in regenerative medicine by offering a reliable way to monitor therapeutic outcomes without repeated invasive procedures.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI